Denis S. Burminskiy

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission

Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: August 29, 2022

An effect of cholinesterase blockade on negative symptoms in schizophrenia

An effect of cholinesterase blockade on negative symptoms in schizophrenia

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: September 05, 2021

Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.

Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.

Journal: Journal of psychiatric research

Published: March 02, 2021

Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia.

Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia.

Journal: Neuropsychobiology

Published: February 01, 2021

The activity of erythrocyte and platelet glutathione reductase and glutathione-S-transferase in paranoid schizophrenia

The activity of erythrocyte and platelet glutathione reductase and glutathione-S-transferase in paranoid schizophrenia

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: December 27, 2018

Positive changes in the severity of residual psychotic symptoms in schizophrenic patients switched to treatment with risperidone

Positive changes in the severity of residual psychotic symptoms in schizophrenic patients switched to treatment with risperidone

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: June 16, 2017

5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).

5-HT6 Receptor Antagonist as an Adjunct Treatment Targeting Residual Symptoms in Patients With Schizophrenia: Unexpected Sex-Related Effects (Double-Blind Placebo-Controlled Trial).

Journal: Journal of clinical psychopharmacology

Published: February 01, 2017

Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with attack-like progressive form of schizophrenia: a longitudinal study

Variants of changes in the psychopathological phenomenology of the long-term remission in stable patients with attack-like progressive form of schizophrenia: a longitudinal study

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: September 11, 2015

Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation

Plasma levels of antipsychotics and the severity of side-effects in the treatment of schizophrenia exacerbation

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 01, 2015

Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.

Add-on clinical effects of selective antagonist of 5HT6 receptors AVN-211 (CD-008-0173) in patients with schizophrenia stabilized on antipsychotic treatment: pilot study.

Journal: CNS spectrums

Published: June 18, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026